1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGlobal Infectious Disease (GID) Research Training Programs (FIC) is sponsored by National Institutes of Health (NIH) - Fogarty International Center (FIC). This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U. S.
and low- and middle-income country (LMIC) institutions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Global Infectious Disease Research Training (D43 D71) - Fogarty International Center @ NIH NIH Websites Are Changing Get the Latest Updates and FAQs Global Infectious Disease Research Training NIH’s policy on non-U.S. subawards has changed . NIH is establishing a new award structure that will prohibit foreign subawards from being nested under the parent grant.
Until this policy is in place, NIH will not issue awards to domestic or foreign entities that include a subaward to a foreign entity. Applications with non-U.S. subawards will not be accepted by NIH for review and will be automatically withdrawn. Applicants are advised not to use non-U.S. subawards.
Global Infectious Disease Research Training Program ( D43 Clinical Trial Optional) (PAR-24-174) Country eligibility for Fogarty international training grants Applicant institutions may submit more than one application, provided that each application is scientifically distinct. U.S. institutions with a demonstrated collaboration with a researcher at a LMIC institution may apply. Foreign institutions in LMICs may also apply.
Applicant institution must have robust and high-quality research ongoing in the areas proposed. D43 Eligibility Information for more details. Global Infectious Disease (GID) research training program addresses research training needs related to infectious diseases that are predominantly endemic in or impact upon people living in developing countries.
The training programs include a variety of research training options to match the needs of the developing country institution. Program focus on a major endemic or life-threatening emerging infectious disease, neglected tropical disease, infections that frequently occur as a co-infection in HIV infected individuals, or infections associated with noncommunicable disease conditions of public health importance in LMICs.
The ultimate goal is to build a critical mass of researchers and support staff to conduct independent infectious disease research in developing country institutions.
Training programs may include: Long-term (master's or doctoral degree and other training that is six months or longer) training for the full range of skills necessary to support research and research administration with the understanding that the focus of thesis and training-related research will be in their country.
Medium-term (three- to up to six-months) training or mentoring, including specialized clinical, laboratory, research or administrative/business skills necessary to support research that is planned or ongoing.
Short-term (less than three months) training or mentoring that focuses on research methodology, laboratory skills necessary to support research ethics and compliance issues, program and grants administration and financial management, grant writing, preparation of scientific manuscripts, data management, informatics, and other relevant areas.
Institutional capacity-building efforts such as in-country training workshops in advanced research techniques, distance learning and informatics. Advanced in-country mentored research undertaken by the trainee in their home country upon completion of his/her initial period of long-term training under the program.
Starting with 2019 application deadlines, D71 planning grants are eligible for up to two years of support, with increased funds for training resources, including faculty strengthening activities; development of advanced course and training resources; and training program evaluation. View a full list of Global Infectious Diseases (GID) Research Training grant awards by institution.
Division of International Training and Research Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 Telephone: (301) 402-9467 Grants Management Specialist Fogarty International Center 31 Center Drive, MSC 2220 Satabdi. Raychowdhury@nih. gov The D43 announcement is issued by Fogarty in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) .
Nutritional research in Tanzania may help coal miners in the U.S. Global Health Matters , July/August 2025 This infectious disease expert helped build Uganda’s research infrastructure Global Health Matters , September/October 2023 Peru’s research infrastructure, supported by Fogarty, continues to blossom Global Health Matters , July/August 2023 UB, partners receive $1.
5 million NIH grant for infectious disease training program University of Buffalo news, April 11, 2023 Fogarty Grant Recipient & Trainee Publications Risk of arboviral transmission and insecticide resistance status of Aedes mosquitoes during a yellow fever outbreak in Ghana , co-authored by Fogarty grant recipient Yaw Asare Afrane BMC Infectious Diseases , July 25, 2025 Prognostics of multiple malaria episodes and nutritional status in children aged 6 to 59 months from 2013 to 2017 in Dangassa, Koulikoro region, Mali , co-authored by Fogarty grant recipient Seydou Doumbia and Fogarty trainees Soumba Keita, Mahamoudou Toure, Daouda Sanogo and Mahamadou Diakite Malaria Journal , June 13, 2024 Seroprevalence of Human T-Cell Lymphotropic Virus-1 in a Jamaican Antenatal Population and Assessment of Pooled Testing as a Cost Reduction Strategy for Implementation of Routine Antenatal Screening , co-authored by Fogarty trainees Ynolde Leys, Tiffany Butterfield, and Jacynth Moore The American Journal of Tropical Medicine and Hygiene , October 23, 2023 Resurgence of Malaria Transmission and Incidence after Withdrawal of Indoor Residual Spraying in the District of Koulikoro, Mali , co-authored by Fogarty grant recipient Seydou Doumbia and Fogarty trainees Mahamoudou Touré, Drissa Konaté, Mahamadou Diakité, and John Beier The American Journal of Tropical Medicine and Hygiene , September 6, 2023 Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh , co-authored by Fogarty grantees Stephen Calderwood, Firdausi Qadri, and Edward Ryan, and Fogarty trainees Mohammad Kamruzzaman and Richelle Charles mSphere , August 30, 2023 Amblyomma cajennense and Rhipicephalus microplus ticks collected in Colombia , co-authored by Fogarty grant recipients Patricia Aguilar and Juan Rodas, and Fogarty trainee Francisco Díaz Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants , co-authored by Fogarty grant recipients Edward T.
Ryan and Firdausi Qadri mSphere , February 23, 2024 Association of severe malaria with cognitive and behavioural outcomes in low- and middle-income countries: a meta-analysis and systematic review , co-authored by Fogarty Advisory Board member Chandy John Malaria Journal , August 3, 2023 Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-21-120) Grants awarded through PAR-21-120 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71 Clinical Trials Not Allowed) (PAR-19-362) Grants awarded through PAR-19-362 in NIH RePORTER Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-20-229) Grants awarded through PAR-20-229 in NIH RePORTER Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-18-840) Grants awarded through PAR-18-840 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-17-058) Grants awarded through PAR-17-058 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-15-160) Grants awarded through PAR-15-160 in NIH RePORTER Global Infectious Disease Research Training Program (D43) (PAR-14-193) Grants awarded through PAR-14-193 in NIH RePORTER Global Infectious Disease Research Training Program (D71) (PAR-14-194) Grants awarded through PAR-14-194 in NIH RePORTER Global Infectious Disease Research Training Program (D43) (PAR-10-260) Grants awarded through PAR-10-260 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-10-262) Grants awarded through PAR-10-262 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PAR-08-154) Grants awarded through PAR-08-154 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PAR-05-128) Grants awarded through PAR-05-128 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PA-03-012) Grants awarded through PA-03-012 in NIH RePORTER
According to the current listing, eligibility includes: U. S. and low- and middle-income country (LMIC) institutions. Confirm the full requirements in the official notice before applying.
Global Infectious Disease (GID) Research Training Programs (FIC) is funded by National Institutes of Health (NIH) - Fogarty International Center (FIC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes is sponsored by National Institutes of Health (NIH) - Fogarty International Center (FIC). This initiative supports research on the development, validation, feasibility, and effectiveness of innovative digital health interventions or tools (including mobile health) specifically suited for underserved settings in the U.S. and globally. It emphasizes reciprocal innovation methodologies, which involve a bidirectional exchange of ideas and resources to address shared health challenges between U.S. and low- and middle-income country (LMIC) researchers.
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) - Fogarty International Center (FIC). This program encourages joint applications from U. S. and low- and middle-income country (LMIC) institutions to develop collaborative training programs that strengthen the capacity of LMIC institutions to conduct infectious disease research.
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) - Fogarty International Center (FIC). This funding opportunity supports exploratory or developmental research studies that identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions.
Notice of Award of a Sole Source Cooperative Agreement To Fund Ministry of Health, Bhutan; National Influenza Center, Mongolia; Research Institute for Tropical Medicine, Philippines; Bangkok Metropolitan Administration, Thailand is sponsored by Health and Human Services Department; Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces four separate awards to fund the Ministry of Health, Bhutan; National Influenza Center, Mongolia; Research Institute for Tropical Medicine, Philippines; Bangkok Metropolitan Administration, Thailand. For Ministry of Health, Bhutan, the award is for approximately $800,000 in Federal Fiscal Year (FFY) 2026, subject to the availability of funds. For National Influenza Center, Mongolia, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. For Research Institute for Tropical Medicine, Philippines, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. For Bangkok Metropolitan Administration, Thailand, the award is for approximately $900,000 in FFY 2026, subject to the availability of funds. The total FFY 2026 funding amount for the four recipients is $2,900,000. Funding amounts for years 2-5 for each recipient will be set at continuation. The awards will enhance health security by strengthening global influenza and other priority pathogen surveillance networks to detect and respond to infectious disease threats. Action: Notice. Published in the Federal Register on 2026-08-05. Federal Register document number: 2026-15903.
Notice of Award of a Single Source Cooperative Agreement To Fund Association Institut National Hygiene Publique, Cote d'Ivoire; Ministry of Health-Centers for Disease Control and Prevention, Egypt; Ethiopian Public Health Institute; Noguchi Memorial Institute for Medical Research, Ghana; Institut National d Hygiene, Morocco; Institut Pasteur de Dakar, Senegal; Institut Pasteur de Tunis, Tunisia; Uganda Virus Research Institute; University Teaching Hospital, Zambia is sponsored by Health and Human Services Department; Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces nine separate awards to fund Institut National Hygiene Publique, Cote d'Ivoire; Ministry of Health-Centers for Disease Control and Prevention, Egypt; Ethiopian Public Health Institute; Noguchi Memorial Institute for Medical Research, Ghana; Institut National d Hygiene, Morocco; Institut Pasteur de Dakar, Senegal; Institut Pasteur de Tunis, Tunisia; Uganda Virus Research Institute; University Teaching Hospital, Zambia. For Institut National Hygiene Publique, Cote d'Ivoire, the award is for approximately $800,000 in Federal Fiscal Year (FFY) 2026, subject to the availability of funds. For Ministry of Health-Centers for Disease Control and Prevention, Egypt, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Ethiopian Public Health Institute, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Noguchi Memorial Institute for Medical Research, Ghana, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Institut National d Hygiene, Morocco, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. For Institut Pasteur de Dakar, Senegal, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Institut Pasteur de Tunis, Tunisia, the award is for approximately $600,000 in FFY2026, subject to the availability of funds. For Uganda Virus Research Institute, the award is for approximately $900,000 in FFY 2026, subject to the availability of funds. For University Teaching Hospital, Zambia, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. The total FFY 2026 amount for the nine recipients is $6,7000,000. Funding amounts for years 2-5 for each recipient will be set at continuation The awards will enhance health security by strengthening global influenza and other priority pathogen surveillance networks to detect and respond to infectious disease threats. Action: Notice. Published in the Federal Register on 2026-08-05. Federal Register document number: 2026-15899.
Notice of Award of a Single Source Cooperative Agreement To Fund Institute of Epidemiology, Disease Control and Research, Bangladesh; National Institute of Public Health, Cambodia; Institut Pasteur de Madagascar; National Health Laboratory Service, South Africa; L.Sakvarelidze National Center for Disease Control and Public Health, Georgia. is sponsored by Health and Human Services Department; Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces five separate awards to fund Institute of Epidemiology, Disease Control and Research, Bangladesh; National Institute of Public Health, Cambodia; Institut Pasteur de Madagascar; National Health Laboratory Service, South Africa; L.Sakvarelidze National Center for Disease Control and Public Health, Georgia. For Institute of Epidemiology, Disease Control and Research, Bangladesh, the award is for approximately $1,000,000 in Federal Fiscal Year (FFY) 2026, subject to the availability of funds. For National Institute of Public Health, Cambodia, the award is for approximately $1,000,000 in FFY 2026, subject to the availability of funds. For Institut Pasteur de Madagascar, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For National Health Laboratory Service, South Africa, the award is for approximately $1,000,000 in FFY 2026, subject to the availability of funds. For L. Sakvarelidze National Center for Disease Control and Public Health, Georgia, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. The total FFY 2026 funding amount for the five recipients is $4,600,000. Funding amounts for years 2-5 for each recipient will be set at continuation The awards will enhance health security by strengthening global influenza and other priority pathogen surveillance networks to detect and respond to infectious disease threats. Action: Notice. Published in the Federal Register on 2026-08-07. Federal Register document number: 2026-16110.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article